In addition, LILRB1 has also been linked to metabolic pathways, including cholesterol homeostasis and ferroptosis resistance in malignancies such as multiple myeloma, underscoring its functional relevance beyond transplant immunology and highlighting its potential as a target for novel therapeutic strategies (92). Here, LILRB1 is linked to AL amyloidosis.